External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology SSG 2023
Roche and Genentech at

SSG 2023

September 14 - September 15
Bern, Switzerland
sgg-sgvc-sasl.unibas.ch
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Sep 14 / Roche
Cost-effectiveness of Hepatocellular Carcinoma (HCC) Surveillance Strategies in Switzerland
This is the first study evaluating the cost-effectiveness of different HCC surveillance strategies in Switzerland (including the novel GAAD algorithm, ultrasound plus the serum biomarker AFP, and ultrasound alone) in patients with CLC, non-cirrhotic HBV and FIB3 fibrosis.
Oncology HealthTech Hepatocellular Carcinoma SSG-2023
02:40 PM
Duration 10mins Kongresssaal, Congress Centre Kursaal Interlaken, Interlaken, Switzerland
Cost-effectiveness of Hepatocellular Carcinoma (HCC) Surveillance Strategies in Switzerland
Goossens N, Garay O, Wolf C, Ambuhl L, Kugler V, Girardin F
Oncology - HealthTech | Hepatocellular Carcinoma

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.